|Grant Affiliation:||Third party request|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2014-05-14|
|Study Made Public:||2016-01-15|
Evaluating strategies to subvert self-tolerance as a suppression mechanism in the induction of 2F5-like MPER antibodies
CAVD 516 is a pre-clinical mouse study evaluating "nearest neighbor" prime/boost vaccine strategies using mutant human Kynu, wildtype human Kynu, gp140, and MPER liposomes.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.